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Abstract
Background: Interferon-gamma release assays (IGRA) are used for tuberculosis (TB) screening in healthcare workers
(HCWs). However, data on specificity of IGRA in serial testing of HCWs is sparse. Therefore the specificity and the
negative predictive value of the IGRA - QuantiFERON-TB Gold In-Tube (QFT) - in German nursing students was
investigated.
Methods: 194 nursing students at the start of their professional career were tested with the QFT. 14 nursing
students were excluded from the specificity analysis, due to exposure to mycobacterium tuberculosis. Two of these
subjects were QFT- positive. None of them developed disease during the year of follow-up. A study group of 180
students, all with very low risk of prior TB infection, remained in the specificity analysis. Subjects were monitored
for at least two years with respect to the development of active TB disease. IGRA was performed at the start of the
training and after one year.
Results: The mean age of the study group (n = 180) was 23 years (range 18-53) with 70.9% female and 99.4% German
born. The specificity of QFT was 98.9% (178/180; 95% CI 0.96-0.99); lowering the cut-off from 0.35 IU/ml to 0.1 IU/ml
would have decreased specificity only slightly to 97.8% (176/180; 95% CI 0.94-0.99). Of the 154 nursing students
available for re-testing, one student who initially scored positive reverted to negative, and one student initially negative
converted to positive. None of the monitored group with initially negative QFT results developed TB disease, indicating
a high negative predictive value of the IGRA in this population.
Conclusions: Following our data, QFT can serve as an effective tool in pre-employment TB screenings for HCWs.
As its negative results were stable over time, specificity of the QFT in serial testing of HCWs is high. As the risk of
acquiring TB infection in the German healthcare system appears to be low, our data supports the recommendation
of performing TB screening only in those HCWs with known contact to TB patients or infectious materials.
Background
Screening healthcare workers (HCWs) for latent tubercu-
losis infection (LTBI) and active tuberculosis (TB) disease
is a fundamental aspect of infection control programmes
in hospitals [1]. The tuberculin skin test (TST) was the
first method available for detecting LTBI. However, the
TST has known limitations, including cross-reactivity with
bacillus Calmette-Guérin (BCG) and non-tuberculous
mycobacteria (NTM) infections [2]. Recently, new in-vitro
assays have been developed that measure interferon (IFN)-
g released by sensitised T cells after stimulation with
Mycobacterium tuberculosis antigens. These tests
are more specific than the TST since they use antigens not
shared by any of the BCG vaccine strains and only by
few NTM species (namely M. marinum, M. szulgai,
M. kansasii, and M. riyadhense [3] that are still rarely
detected in clinical settings, but that often have clinical
relevance [4] Although in most slow-growing NTM-spe-
cies ESX-5, a duplication of RD1 and its secretion system
(ESX-1) has been detected, the secretion products seem to
be secretion system specific [5] and thus do not seem to
influence the specificity of the IGRA-assays. Interferon-g
release assays (IGRAs) also have the advantage of correlat-
ing better with surrogate measures of exposure to
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LTBI progression to active TB disease in close contact in
low-incidence settings [9].
Despite a steadily increasing flood of studies on the use
of interferon gamma release assays (IGRAs) in detecting
latent TB infection (LTBI), the number of studies evalu-
ating specificity, i.e. measuring a test’s ability to score
LTBI-free subjects as test-negative, is small [10]. Due to
the lack of a gold standard to ascertain LTBI in a study
individual, specificity can only be measured in healthy
subjects who report no known risk for prior M. tubercu-
losis (MTB) exposure and - as far as possible - in an
environment that itself offers little or no chance of spon-
taneous, unrecognised transmission to the test popula-
tion. Therefore, studies to test a hypothesis of high
specificity should be conducted in low prevalence coun-
tries where the risk of unnoticed exposure to MTB can
be considered negligible. As a more specific test will pro-
duce fewer positive results than a less specific test with
identical sensitivity, doubts may arise as to the sensitivity
of the more specific test. In the absence of a gold stan-
dard, reliable proxy measurements for sensitivity are
needed. The negative predictive value (NPV), i.e. the
probability that a test-negative person is actually nega-
tive, is one such proxy for sensitivity. In the case of tests
for LTBI, where the consequence of a false negative test
may only become apparent long after the test date, the
NPV of a test can only be measured in terms of its NPV
for progression to active TB disease. As HCWs may be
subjected to serial testing for LTBI over the course of
their careers, high specificity of the test applied is of
particular importance. Some paper gave concern to the
specificity of the QFT as they observed high conversion
and reversion rates. Therefore we examined the accuracy
a n ds p e c i f i c i t yo ft h eQ F Ti naf o l l o w - u ps t u d yo n
low exposed students entering nursing schools in a low-
incidence country.
Methods
Study design
Our study group consisted of nursing students (18 years of
age or older), trained for work in nursing homes and
hospitals, starting their professional career in healthcare
institutions operated by the healthcare provider Vivantes
(*Institut für berufliche Bildung im Gesundheitswesen
(IbBG) Vivantes) in Berlin. Participation was on a volun-
tary basis. Participants were asked to complete a standar-
dised questionnaire before starting their career in
healthcare; questions addressed national origin, whether
foreign born, how long they had been living in Germany,
possible risk factors for prior exposure to MTB, history of
TB disease, inclusion in TB contact tracing exercises in
the past, and BCG vaccination status.
One year after enrollment, a second QFT was performed
and a new standardised questionnaire was implemented,
soliciting information as to specific activities undertaken
in the course of the year. Questions addressed the wards
or fields of healthcare to which the participants had been
assigned, the time period spent there, contact with TB
patients and, if any, type and duration of contact. In addi-
tion, participants were quizzed on non-professional TB
risks such as cases of TB disease in the family or among
friends and acquaintances, or journeys of two weeks or
longer to high-incidence countries during the first year of
work. Each individual was monitored with respect to the
development of TB disease for a further year.
Student nurses with risk factors for prior TB infection,
including birth in a country with a high TB prevalence,
were not taken into account during the analysis of specifi-
city. The study design was approved by the Ethics Com-
mittee of the Hamburg Medical Council in Hamburg,
Germany.
Definitions of specificity and negative predictive value
(NPV) for progression
Specificity is defined as the number of true negatives
divided by the sum of true negatives and false positives.
The NPV for progression to active TB is defined as the
proportion of test-negative subjects that do not progress
to active tuberculosis in a longitudinal follow-up study of
individuals tested for LTBI. This value reflects a test’s abil-
ity to correctly predict that an individual who tested nega-
tive for LTBI will not develop active tuberculosis later on
in life, assuming that no further exposure to MTB takes
place. As only subjects infected with M. tuberculosis can
develop the disease, the NPV can be measured by follow-
ing subjects that tested negative for LTBI over time and
quantifying the number that have remained free from pro-
gression to active disease.
QuantiFERON Gold In-Tube (QFT) was performed
according to the manufacturer’s instructions (Cellestis
Ltd., Chadstone, Australia). As recommended, the cut-off
value for a positive test was IFN-g ≥ 0.35 IU/ml for the
TB-antigen minus NIL, provided the NIL control was <
8.0 IU/ml and the TB-antigen minus NIL response was at
least 25% of the NIL response. The result was indetermi-
nate if the NIL was > 8.0 IU/ml or if not positive and the
mitogen control minus NIL value was ≤ 0.5 IU/ml. All
other result profiles provided a negative result. The vali-
dated linear range of the QFT ELISA, as reported by the
manufacturer, is 0 to 10 IU/ml, thus any value above
10 IU/ml is reported as > 10 IU/ml.
Statistical analysis
The categorical data was compared using the Pearson’s
c
2 test or Fisher’s exact test, when expected sample
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signed-rank sum test was performed to determine
whether the means of two repeated measurements of
IFN-g concentrations differed. All P values reported are
based on two-tailed comparisons with statistical signifi-
cance set at P < 0.05. Statistical analyses were performed
using SPSS version 18.0 for Windows (SPSS, Inc., Chi-
cago, IL) and BIAS version 8.3.6 for Windows (Epsilon,
Inc., Frankfurt, Germany).
Results
Study group at the start
In all, 194 persons were enrolled between 1 October 2008
and 30 April 2009. The cohort was observed until 30 April
2011 (Figure 1) with a mean period between the first and
second IGRA of 17 month (standard deviation 2 month).
Of the participants, 104 were distributed to 69 different
departments (e.g. gastroenterology, psychiatry, infection
ward, etc.) in 33 different hospitals or 68 different depart-
ments of these hospitals. The other 90 nursing students
worked in numerous nursing homes, rehabilitation centres
and mobile nursing services. There were 13 members
born in intermediate or high-prevalence TB countries
(Cameroon, Poland, Ethiopia, Nepal, Romania, Pakistan,
Kosovo, Turkey, Albania, Russia), of whom a 20-year-old
woman who moved from Ethiopia to Germany in 2002
was QFT-positive (2.05 IU/ml), all other 12 subjects had
negative QFT-results. One 18-year-old German male
151 students remained 
negative; 1 QFT-positive 
reverted to negative, 1 QFT-
negative converted to 
positive, 1 remained positive.
194 student nurses included 
and tested with QFT; 
4 individuals tested QFT-
positive; of those
1 woman from Ethiopia,
1 contact person of infectious 
TB patient, 2 with unknown 
risk
180 student nurses with very 
low TB risk (178 QFT-
negatives and 2 QFT-
positives) comprised 
specificity group 
14 Students excluded:
13 students from 
intermediate/high-burden
countries (1 QFT positive/ 12 
negative) and one contact 
person (QFT positive) not 
fulfilling inclusion criteria for 
specificity
40 students dropped out of 
the nursing profession 
within a year; of those 2 
were QFT-positive
154 students (152 QFT-
negatives, 2 QFT-positive) 
retested after 1 year 
Follow- up Specificity analysis
Figure 1 Steps for building the group for analysing specificity and NPV.
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(> 10 IU/ml) due probably to close contact with an infec-
tious TB patient as this student had worked in healthcare
before the training started. However, this link could not be
established with certainty. These 14 students were
excluded from the specificity analysis. Details of the study
population are shown in Table 1.
Specificity
Of the remaining 180 subjects with very low risk of MTB
infection, two study members, females aged 22 and 42
years, were QFT-positive with a difference of TB antigen-
NIL of 1.75 IU/ml and 0.67 IU/ml, respectively. None of
the study members had an indeterminate result (Figure 2).
None of the study population showed high nil- controls
(range from 0.00 to 0.18 IU/ml). Therefore, nobody was
IGRA-negative due to the fact of a high nil control. Esti-
mated specificity for the QFT was therefore 98.9% (178/
180; 95% CI 0.96-0.999). The mean age of the specificity
group was 22.96 ± SD 5.78 (min, max: 18, 53). Members
were predominately female (128, 71.1%), and 86 (47.8%)
had been BCG vaccinated, of whom BCG vaccination was
certificated by a vaccination pass in 85 and one women
without certification had a vaccination scar. There was no
statistical difference between BCG-vaccines with respect
to gender and country of birth. 179 of the low-risk persons
were born in Germany, whereas the remaining subject, a
47-year-old man was born in Chile. A lowering of any cut-
off value in a test compromises specificity for the supposed
benefit of added sensitivity. In our study, if the cut-off (TB
AG-NIL) is lowered to 0.10 IU/ml, only two more subjects
w o u l db ep o s i t i v ew i t hv a l u e so f0 . 1 9I U / m la n d
0.22 IU/ml; this would reduce our specificity estimate only
slightly, to 176/180 (97.8%; 95% CI 0.94-0.99).
Follow up results
Of the 194 study participants initially included in the
study, 154 were retested one year after enrollment. The
remaining 40 student nurses (20.6%) had dropped out of
the training programme. Among the 154 retested health-
care workers, one reverted from a positive to a negative
QFT result (from 1.75 IU/ml to 0.00 IU/ml) and one of
the persons initially negative converted from negative to
positive (from 0.01 IU/ml to 0.68 IU/ml) (Figure 3). The
average IFN-g level of the tested individuals was
unchanged between the first testing and the second testing
(p = 0.28, n.s.) with a mean of 0.053 ± 0.043 SD in the first
and 0.039 ± 0.097 SD in the second QFT. There was no
statistical difference between the 40 subjects who dropped
out and the remaining 154 HCWs with respect to age, sex,
BCG vaccination and origin. 35 of the 154 (22.7%) stu-
dents had contact to patients with active TB (22 sputum
positive patients) during the year between the first and the
second QFT tests. However, the student with a conversion
in QFT result worked in a nursing home and had no
known contact to TB patients (data not shown). Nonethe-
less, they were followed for progression to active TB for
the whole two years. The NPV for progression was 100%,
i.e. not a single one of the healthcare workers developed
TB disease during the study period
Discussion
To our knowledge, this is the first specificity study which
includes repeated testing and a follow-up period for
Table 1 Demographic parameters of the 194 study
participants
Variables N %
Male 58 29.9
Female 136 70.1
Age (years)
18 to < 25 153 78.9
25 to < 35 26 13.4
35 to < 45 8 4.1
45+ 7 3.6
BCG vaccination
No 93 47.9
Yes 101 52.1
Born in low-incidence country
No 13 6.7
Yes 181 93.3
German origin
No 14 7.2
Yes 180 92.8
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Figure 2 Dot plot of individual responses to QFT for 180
subjects with valid results and with low risk for TB exposure.
The dashed line represents the cut-off of 0.35 IU/ml for IFN-g.
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regulatory frameworks of the respective countries, indivi-
duals with contact to infectious TB cases must be investi-
gated so as to prevent the spread of TB disease. However,
testing of larger groups of persons in low-incidence
countries without any known TB risk is difficult to exe-
cute, given ethical considerations. As a result, the num-
ber of persons whose presumed lack of infection with
MTB is confirmed by a negative IGRA result is relatively
low and study groups are quite heterogeneous. The gen-
eral situation, therefore, does not lend itself to the perfor-
mance of specificity studies.
Up to now, only six published studies evaluated the spe-
cificity of commercially available IGRAs, i.e. QFT and/or
T-SPOT.TB, in a total of 736 subjects with valid IGRA
results fulfilling the inclusion criteria, i.e. excluding studies
performed in intermediate-incidence countries. The study
conducted by Detjen et al. included 45 children with con-
firmed non-TB lymphadenitis or respiratory infections
[11], Pallazo et al. [12] included 24 healthy blood donors
as controls for TB suspects, and Ruhwald et al. [13] 86
high school students and 38 members of the high school
staff. In the paper published by Franken et al. [14] 168
recruits in the Dutch Armed Forces could be considered
as having little risk. Wang et al. [15] included 97 adult uni-
versity volunteers and eleven hospital children, and the
study by Bienek and Chang [16] comprised 278 persons in
the low-risk group of U.S.-born Navy recruits. According
to these studies, the specificity of the IGRAs ranged from
96.9% (95% CI 94.2-98.6%) [10] for the T-SPOT.TB ("Eur-
opean cut-off” without any grey zone) to 100% (95% CI
97.6-100%) for the QFT.
Our study of healthcare trainees just starting their
active careers confirms the high specificity of the QFT at
nearly 99% and thus presents numbers nearly identical to
the estimates of between 98.8% and 100% of the four
already published studies in which the specificity of QFT
was examined. In addition, however, we retested our
individuals after one year and followed them for two
years in order to investigate whether a false-negative per-
son not recognised by the test would develop TB disease
in the near future. Of the 152 retested persons with initial
QFT-negative results who were monitored for at least
two years, none fell ill and therefore the NPV for pro-
gression was 100%. However, one of the 152 retested par-
ticipants with an initial QFT-negative result, a student
nurse in a nursing home, converted to a positive result.
As there was no source of infection identified, the reason
for the conversion remains unexplained. Some studies
about serial testing in HCWs suggested the use of a grey
zone from > 0.2 to 0.7 IU/ml for the QFT results in serial
examinations [17-19]. Using this grey zone in our study
we found no conversion. As LTBI prevalence in geriatric
nurses was reported to be higher than in other HCWs
[20] and the student worked in a nursing home, the con-
version might be caused by a fresh infection of an
unknown source occurring after the first testing. Over
the same period, the individual who initially scored posi-
tive then reverted to negative.
No further latent TB infection appears to have occurred,
although the medical activities of the study participants
were carried out in 68 different hospitals (or different
departments of those hospitals, including infection wards),
in nursing homes and mobile nursing services and 35 stu-
dents indicated that they had contact to TB patients. This
data indicates that in Germany the chance of acquiring TB
infection through work in the healthcare sector is low.
Schablon et al. [21] tested 2,028 employees in the health-
care sector with the QFT test between December 2005
and May 2009, either in the course of contact tracing or in
serial testing of TB high-risk groups pursuant to German
OSH legislation, but even then a positive IGRA was found
in only 9.9% of the HCWs.
Nevertheless, it was highlighted in a recent systematic
review that conversion of IGRA serial testing results is
common among HCWs [22]. Two recent serial testing
studies among German HCWs found conversion rates of
between 1.9% [17] and 5.2% [18]. In Portuguese HCWs
the conversion rate was 11% [19]. The higher conversion
rate in Portuguese HCWs compared to in German
HCWs is in agreement with the higher TB incidence in
the Portuguese population. Furthermore, the conversion
rates are similar to those described in a meta-analysis for
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Figure 3 Dot plot of individual responses to QFT for 154
healthcare workers available for a second test one year after
initial testing. The dashed line represents the cut-off of 0.35 IU/ml
for IFN-g.
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serial testing was performed because of known contact to
TB patients or infectious materials. Only 14.3% of the
student nurses had contact to TB patients within the one
year between the two QFTs. Exposure was therefore
lower than in the two other German serial testing studies
[17,18] and a low conversion rate was expected. The con-
version rate actually observed was as low as 0.7% (1 out
of 153). This indicates a high specificity of the QFT and a
good reproducibility of negative QFT results.
The inclusion of a follow-up period in our specificity
analysis strengthens our study. However, our study also
has limitations. First of all the sample size is rather
small. Furthermore, the study was carried out in a popu-
lation that was not completely free of potential exposure
to MTB. But as only one conversion occurred, results
were not substantially diluted by performing our study
with nursing students.
Conclusions
Based on our data, it must be asked whether comprehen-
sive serial testing of HCWs following pre-employment
screening remains an expedient preventive measure, at
least outside of high-risk settings such as TB wards or
laboratories. However, as the reproducibility of negative
QFT is high, QFT could conceivably be used to monitor
the hygiene standards in wards where contact to TB
patients or infectious material is to be suspected.
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